ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L03AA02 | BioTech | Filgrastim - 300mcg/0.5ml | 10777 | 102719/1 | ZARZIO | 30MU/0.5ml | 5 | Injectable solution | Infusion | Khalil Fattal & Fils S.A.L. | Sandoz GmbH, Langkamfen | Austria | 9,298,639 L.L | 19.35 | D | Sandoz GmbH | Austria | 1/4/2023 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L03AA02 | BioTech | Filgrastim - 300mcg/0.5ml | 6305 | 166848/11 | ZARZIO | 30MU/0.5ml | 5 | Injectable solution | Infusion | Khalil Fattal & Fils S.A.L. | IDT Biologika GmbH | Germany | 9,298,639 L.L | 19.35 | D | Sandoz GmbH | Austria | 1/4/2023 |
L03AA02 | BioTech | Filgrastim - 300mcg/0.5ml | 7965 | 4815/1 | NEUPOGEN | 300mcg/0.5ml | 1 x 0.5ml | Injectable solution | Infusion/SC | Mersaco | Amgen Europe BV | The Netherlands | 3,567,564 L.L | 23.08 | B | Amgen Europe BV | The Netherlands | 1/4/2023 |
L03AA02 | BioTech | Filgrastim - 30MIU/0.5ml | 9984 | 144718/1 | NIVESTIM | 30MIU/0.5ml | 5 | Injectable solution | Infusion/IV | Food & Drug Corporation FDC | Hospira Zagreb D.O.O. | Croatia | 11,470,891 L.L | 19.35 | D | Hospira UK Ltd | UK | 1/4/2023 |
L03AA02 | BioTech | Filgrastim - 30MIU/0.5ml | 10355 | 196319/1 | ZARZIO | 30MIU/0.5ml | 1 | Injectable solution | Infusion | Khalil Fattal & Fils S.A.L. | IDT Biologika GmbH | Germany | 2,184,311 L.L | 23.08 | B | Sandoz GmbH | Austria | 1/4/2023 |